Aktis Oncology, Inc.
AKTS • NASDAQ • Stock Fundamentals
Aktis Oncology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Roden, with a market cap of $1.1B.
Market Cap$1.1B
Employees222.0
CEOMatthew Roden
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Aktis Oncology, Inc. FAQ
Common questions about Aktis Oncology, Inc.
Aktis Oncology, Inc. (AKTS) has a market capitalization of $1.1B and trades on NASDAQ.
Aktis Oncology, Inc. has approximately 222 employees.